Literature DB >> 360841

Drug prescribing during pregnancy. A controlled study of Tennessee Medicaid recipients.

J C Brocklebank, W A Ray, C F Federspiel, W Schaffner.   

Abstract

The effect of pregnancy on prescribing was assessed in a population of pregnant Medicaid recipients and two matched groups of control women. Of the 2,528 gravidas, 62 per cent received systemic legend drugs (excluding dietary supplements) during their pregnancies. White women and women 30 years of age and older were most likely to receive these medications. Systemic anti-infectives were the most frequently prescribed category of drugs (excluding dietary supplements). One fourth of the women received a narcotic-containing drug and 13 percent of the women received psychotropic drugs, most frequently diazepam. Barbiturates and narcotic-containing drugs were often "hidden" a fixed combination medication. In general, prescribing did not decrease as a result of pregnancy. This study and other studies reviewed here emphasize the need for comprehensive drug-use guidelines for physicians who care for pregnant women.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 360841     DOI: 10.1016/0002-9378(78)90887-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  The cost effectiveness of drug utilisation review in an outpatient setting.

Authors:  D H Kreling; D A Mott
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

2.  Investigating drug use in pregnancy. Methodological problems and perspectives.

Authors:  L T De Jong-van den Berg; P B Van den Berg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

3.  Drug use in pregnancy: an overview of epidemiological (drug utilization) studies.

Authors:  M Bonati; R Bortolus; F Marchetti; M Romero; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

5.  Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy.

Authors:  P C Rubin; G F Craig; K Gavin; D Sumner
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

6.  Information on drug use in pregnancy from the Viewpoint Regional Drug Information Centre.

Authors:  O Kasilo; M Romero; M Bonati; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Drug use in pregnancy: a comparative appraisal of data collecting methods.

Authors:  L T de Jong-van den Berg; C M Waardenburg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Handling of risk-bearing drugs during pregnancy. Do we choose less risky alternatives?

Authors:  L T De Jong-Van den Berg; P B Van den Berg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1992-04-24

9.  Effects of drug administration in pregnancy on children's school behaviour.

Authors:  L Stika; K Elisová; L Honzáková; H Hrochová; H Plechatová; J Strnadová; B Skop; J Svihovec; M Váchova; O Vinar
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

10.  Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP).

Authors:  F Marchetti; M Romero; M Bonati; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.